Why anesthesia, audit trails, fragmented platforms, and AI-assisted documentation are forcing a rethink of what “the record” actually means.
For years, medicolegal discovery in healthcare operated on a fairly stable assumption: if you could obtain the chart, the audit trail, the medication record, and the surrounding metadata, you could reconstruct what happened with reasonable confidence. That framework was never perfect, but it was functional. It was built for a world in which the medical record was treated as a relatively centralized and mostly human-authored artifact. That world is changing quickly.
What is becoming increasingly clear is that the “record” is no longer a single, stable object. It is now often the downstream product of multiple systems, multiple owners, multiple workflows, and increasingly, multiple forms of machine assistance. Some of those systems reside within the hospital’s core EMR. Some sit in anesthesia-specific charting platforms that may be contracted separately from the hospital record. Some live in pharmacy dispensing and medication management systems. And now, more and more, some of the most important influences on documentation may exist outside the formal medical record entirely, in clinician-facing AI tools that can shape note generation, coding logic, documentation completeness, and even the structure of clinical reasoning before a final note is ever signed.
That shift should concern attorneys, expert witnesses, compliance teams, hospital leaders, and clinicians alike. Because the final chart may no longer tell the whole story of how the chart came to be.
Anesthesia is one of the clearest examples of why this matters. In perioperative care, documentation often spans preoperative assessment, intraoperative physiologic monitoring and interventions, and postoperative recovery. But the systems that capture those phases are not always owned, managed, or exported the same way. In one hospital, the anesthesia record may be deeply integrated into the enterprise EMR. In another, the hospital may run Epic or Cerner while the anesthesia group documents in a separate anesthesia information management system. In still another, the hospital, the anesthesia group, and a third-party vendor may each control different parts of the clinical and operational record. To an attorney, a phrase like “produce the anesthesia chart and audit trail” may sound precise. To the analyst, IT specialist, or vendor representative tasked with actually retrieving it, that same phrase may be frustratingly vague.
This is where legal language often collides with operational reality. Terms such as “designated anesthesia record set” or “all access events” may be conceptually understandable to those immersed in litigation strategy, but they are not always the most effective way to retrieve the right data from the right people. The individuals who actually pull these materials are often far removed from bedside workflow. They may not know how the anesthesia record is structured, whether the hospital owns the anesthesia platform, or how pre-op, intra-op, and post-op content is bundled for export. Many of them are technically competent but operationally isolated from clinical practice. That is not a criticism; it is simply the reality of how healthcare systems are built. When discovery language does not map cleanly onto actual clinical systems, the request may fail long before anyone ever reaches the merits.
For many years, paper records carried the better-known medicolegal weaknesses. They were vulnerable to imprecision, retrospective reconstruction, and limited visibility into the actual sequence and duration of events. In anesthesia, that often meant a clinician reviewing monitor trends, approximating the general physiologic course, and documenting a reasonable narrative of what occurred. That process was imperfect, but its limitations were familiar and visible. Everyone understood, at least in broad terms, what paper could and could not do.
Electronic documentation promised something better: legibility, consistency, timestamps, integration, and easier retrieval. In many ways, it delivered exactly that. But digitization did not eliminate ambiguity. It simply moved the ambiguity into the architecture. Templates can auto-populate. Billing-related elements can be embedded into workflow defaults. Device data may be ingested continuously while user-entered actions remain episodic. Time relationships can appear precise while still depending on system design choices, synchronization issues, or export logic invisible to the end user. What looks like a complete chart on the screen may actually be a composite output assembled from multiple sources, some of which are easily retrievable and some of which are not.
Now AI is adding another layer entirely.
Increasingly, clinicians are using tools that can record encounters, generate notes, suggest edits, recommend missing content, improve coding completeness, and structure documentation in ways that are both operationally useful and potentially invisible to later reviewers. Some of these tools are embedded directly within enterprise platforms. Others are external, clinician-facing systems that generate content before it is copied into the official EMR. That means the signed note may be only the final product of a much larger drafting process. A clinician may enter patient-specific information into an AI-enabled platform, receive a proposed note or summary, modify it, refine it, and only then paste the final version into the medical record. The chart may preserve the final result, but not necessarily the original prompt, the first draft, the intermediate edits, or the suggestions that were accepted and rejected along the way.
That is a profound shift. It means discovery may successfully obtain the final note while missing the process that created it. It means the official record may not fully reveal whether the clinician’s documentation was authored from scratch, AI-assisted, edited from a suggested template, or influenced by external recommendations tied to coding or clinical decision support. It means the real evidentiary trail may now extend beyond the hospital record and into third-party systems that are not routinely captured, not easily subpoenaed, or not clearly owned by the institution whose care is under review.
And this issue extends well beyond note writing. AI tools are increasingly being positioned to influence coding, risk prediction, order suggestions, workflow efficiency, and billing readiness. Health systems are building them. EMR vendors are building them. Private third-party companies are building them. Payers are building their own competing systems to identify inconsistencies, denials, and revenue opportunities from the opposite direction. In practical terms, we are moving into an era where multiple intelligent systems may be shaping the same clinical event, each from its own vantage point and each with its own incentives.
That changes the medicolegal questions we ought to be asking. It is no longer enough to ask, “What does the chart say?” We increasingly need to ask, “What systems influenced the chart? Who owned those systems? What did the clinician see? What was suggested? What was accepted? What was changed? What metadata exists outside the official record? And who, exactly, has the authority or the technical ability to produce it?”
For anesthesia, these questions matter even more because the specialty sits at the center of device integration, medication administration, real-time physiologic data, perioperative workflow, and professional billing. It is one of the most technologically dense clinical environments in medicine. That density creates opportunity for precision, but it also creates blind spots for anyone who does not understand how the systems actually work. This is why smarter discovery is not simply broader discovery. Often, it is staged discovery. Start with the full anesthesia record as it is exported and reviewed in normal operations, including preoperative, intraoperative, and postoperative content. Then, once initial review identifies inconsistencies, escalate toward discrete physiologic data, audit logs, medication metadata, and platform-specific system information. That is not a retreat from rigor. It is a more realistic and more defensible path to the truth.
What is needed now is not just updated language, but a new discovery approach. One that acknowledges the fragmented ownership of healthcare data. One that understands that the hospital may not control the anesthesia platform, the vendor may not control the AI-generated edits, and the final EMR may not fully reflect the process that led to the signed note. One that replaces broad abstractions with operationally literate requests grounded in real workflows and real systems. One that appreciates that in modern healthcare, the difference between what is documented and what is knowable is beginning to widen.
For a long time, we treated the chart as the definitive artifact. Increasingly, it is more accurate to view the chart as a compressed output of a much larger digital process. Some of that process is clinical. Some is technical. Some is templated. Some is vendor-mediated. And some of it is now undeniably AI-shaped. That means the future of discovery will not depend on who asks for the biggest pile of records. It will depend on who best understands what the record actually is, how it was created, what influenced it, and what parts of the story never made it into the official record at all.